Not a catalog. A map of a territory: the doors each person walks through, the tools that open each one, and the art of combining them over time to get everything out of them.
Research Use Only (RUO)Nobody wakes up on a Monday saying "I want to inject a peptide." They wake up wanting something else.
They want to fit into the clothes they stopped wearing. They want the knee to stop hurting on the stairs. They want to look in the mirror and recognize themselves. They want to reach the evening with energy, sleep for real, think clearly, age slowly. The peptide is never the desire: it's the means. That's why this book doesn't start with the molecules. It starts with the doors.
Every person walks through one of two doors: they come to gain a benefit (more muscle, better skin, more energy) or to tackle a problem (excess weight, an injury, insomnia). The compound comes afterward, as the key that opens that door. Everything in these pages is ordered that way: first what you want to achieve, then the tool that achieves it.
The peptide is a tool, not the solution. It truly delivers when you do your part.
That's the thesis running through the whole book. A GLP-1 lowers weight, yes — but if you don't train strength or eat protein, you lose weight and muscle, and end up weaker than before. GHK-Cu rebuilds collagen — but if you don't wear sunscreen, the sun undoes by day what the copper builds by night. The molecule opens the door; the habits decide how far you get in. That's why Book V isn't an appendix: it's half the work.
Throughout the book you'll see an evidence level tag. Not everything carries the same weight: some compounds are FDA-approved with thousands of patients, and others have evidence only in animals or in community clinical practice. We always say so, without dressing it up. Trial figures belong to the molecule, not a promise from a product. And everything, absolutely everything, is Research Use Only (RUO) — none of this is medical advice.
The three laws before touching the first door.
Neither a lab drug foreign to the body, nor a harmless supplement. Something in between, and more interesting than both.
A peptide is a short chain of amino acids — the same bricks your body uses to build proteins, hormones and signals. The difference from a protein is only size: past about 50 pieces we call it a protein; below that, a peptide. That smallness makes it precise. Where a protein is a long letter, a peptide is a one-line order: "repair here," "release this," "calm that."
Many of the ones in this book aren't synthetic inventions: they're copies of messengers your own body already uses and that decline with age. GHK-Cu circulates in your plasma and drops over the years. MOTS-c is written by your mitochondria and falls ~21% as you age. Epithalon mimics a pulse from your pineal gland. Replenishing them isn't adding something foreign: it's restoring a volume that time lowered.
Others are modern high-precision design — GLP-1s like Tirzepatide or Retatrutide mimic gut hormones (incretins) to speak to the brain about appetite. But the logic is the same: speak the body's language, not force it.
A peptide is a chain of amino acids; your stomach is designed precisely to break amino-acid chains and digest them. Taken as a pill, most would be destroyed before doing anything. That's why the typical route is subcutaneous — a fine needle, like insulin's, into the fat under the skin. There are exceptions that work by other routes: Semax and Selank are intranasal; GHK-Cu has a topical (cream) lane with the best evidence of all. Each chapter makes it clear.
A peptide is a signal, not a fuel. You don't "feel" it like caffeine. It gives an instruction to a system in your body, and that system takes time to respond — days or weeks. Whoever expects an instant effect gets frustrated; whoever understands they're reprogramming a process, wins.
Almost everything here is sold as Research Use Only material. It's not a technicality to dodge rules: it means these compounds, in their injectable form and for these uses, are not approved as consumer medicine. Some do have FDA approval for a specific medical use (Tirzepatide for obesity, PT-141 for desire, Tesamorelin for visceral fat) — and we highlight it when it happens, because it changes the weight of the evidence. But the rest live in the territory of research and community practice. Knowing that is part of using them wisely.
The same compound, with the same goal, gives different results depending on when it enters. Timing isn't a detail of the protocol: it is the protocol.
If there's one idea that separates whoever improvises from whoever gets results, it's this: peptides aren't taken "all together to see what happens." They're orchestrated. Each has a rhythm — some are used continuous and rising, others in cycles with rest, others only on demand. And when several goals combine, what decides success is in what order and at what moment each piece enters.
Every combination falls into one of these four modes. Recognizing them is half the battle won.
Not all compounds are used equally often. This is the golden rule by family — and it's also, on the business side, what defines the waves of reorder.
| Family | Rhythm | Why |
|---|---|---|
| GLP-1 (Reta, Tirze) | Continuous, titrating upward. Not cycled. | Stopping = appetite and weight come back. The dose rises slowly, every 4 weeks, without skipping steps. |
| GH axis (Tesamorelin) | Cycled: 8–16 weeks on, 4–8 off. | Continuous use desensitizes the receptor and raises IGF-1 more than desirable. The rest resets it. |
| Recovery (BPC, Wolverine) | Episodic, by goal. | Used until the injury or gut problem resolves, then stopped. Not lifelong. |
| Skin / GHK-Cu | 8–12 week cycles with rest. | Copper accumulates; the rest avoids excess. |
| Longevity (Epithalon) | Short courses, 1–2 times a year. | Its logic is an isolated 10–20 day pineal pulse, not constant use. |
| Libido (PT-141) | On demand. | Used ~45 min before, not daily. Maximum 8 times a month. |
| Antioxidant (Glutathione, NAD+) | Continuous in cycles. | Sustained replenishment of something that drops with age. |
Designing by phases also solves compatibility: what's used in different phases never mixes. If GHK-Cu enters at week 5 and glutathione has already ended, there's no copper conflict to manage. Timing, well thought out, makes half the chemical clashes disappear.
Combining isn't adding. Two good compounds can get in each other's way, duplicate, or cancel out. These are the hard rules — and the why of each.
The beginner's temptation is to stack: "if one is good, five will be better." Almost never. Combining well is an art of fit, not accumulation. Some pairs potentiate, some step on each other, and some sabotage each other chemically. This chapter is the rulebook; each door's chapter applies it case by case.
Compounds that mobilize tissue repair and angiogenesis — TB-500, and therefore Wolverine, Glow and Klow — carry a theoretical signal of possibly feeding unwanted tissue too. Contraindicated in active cancer or a history of it. And several in this book (GLP-1, GH axis, TB-500, MOTS-c) are banned by WADA in competitive sport. If you compete, check first.
Two words that get confused all the time and mean very different things.
A blend is a single vial with several actives already mixed at the factory, in a validated ratio. You open one, you inject one. A stack is a set of separate vials used together as a plan, but each on its own schedule, day or route. The difference matters: what can be pre-mixed without the ingredients fighting goes in a blend; what needs separation (by chemistry or timing) goes in a stack.
| Blend | What it carries | For |
|---|---|---|
| Wolverine | BPC-157 + TB-500 | Athlete recovery: local + systemic repair. |
| Glow | Wolverine + GHK-Cu | Recovery and skin in one vial. |
| Klow | Glow + KPV | The above + reinforced anti-inflammation (gut/skin). |
| Calm Focus | Semax + Selank | Focus and calm, the nootropic pair. |
Notice the containment: Glow is Wolverine plus one thing; Klow is Glow plus one thing. That's why their components are never added separately.
Stacks solve goals no single vial can cover alone, respecting the separations. The main ones:
| Stack | Combines | Door |
|---|---|---|
| Mito Stack | MOTS-c + SS-31 + NAD+ | Cellular energy |
| Recomposition | GLP-1 + MOTS-c + Tesamorelin | Lose fat without losing muscle |
| Recovery | Wolverine + Tesamorelin | Repair + GH axis |
| Longevity / Apex | Epithalon + MOTS-c + SS-31 + NAD+ (+ Glutathione) | Deep anti-aging |
| Glow Up | Glow + Glutathione | Skin: firmness + glow (on different days) |
| Clarity | Calm Focus + NAD+ | Sustained mind |
When two goals land on compatible compounds, the blend beats stacking the loose ones: a single vial, cheaper and simpler. Recovery + skin together → Glow beats buying Wolverine and GHK-Cu separately. The stack is reserved for when chemistry or timing force a separation.
Seven benefits. Seven ways in. Each with its tool and the art of maximizing it.
The busiest door. Also the one most people cross badly, losing exactly what they shouldn't.
Nobody arrives saying "I want a dual incretin agonist." They arrive saying "I don't fit my clothes," "the mirror embarrasses me," "the doctor talked to me about my sugar." Behind that door is the class of compounds that changed the world of obesity: the GLP-1s. They work by speaking to the brain about appetite — they lower hunger, slow stomach emptying, and so the caloric deficit stops being a willpower fight. But they carry a silent cost that this whole chapter exists to solve.
Two options, and the choice matters:
| Compound | What it is | Potency | Evidence |
|---|---|---|---|
| Tirzepatide | Dual agonist (GIP + GLP-1) | −16% to −22.5% of weight | High · FDA |
| Retatrutide | Triagonist (+ glucagon) | Up to −24% to −28%; liver fat −82% | Phase III |
Tirzepatide is the consolidated evidence: FDA-approved, thousands of patients. Retatrutide is the class's peak potency — it adds a third arm (glucagon) that brings energy expenditure and brutal clearing of liver fat — but it's still experimental and raises heart rate a little. The house rule: the default headliner is Retatrutide; you switch to Tirzepatide when the person's safety calls for it.
About 25% of the weight lost with a GLP-1 is muscle, not fat. The compound slims without distinguishing. Whoever drops 20 kilos doing nothing else loses ~5 kilos of lean mass — and muscle is what holds up the metabolism. The classic result of ignoring it: "skinny-flabby," with a slower metabolism than at the start, ready to rebound. Everything that follows exists to avoid that.
The GLP-1 has a continuous, rising rhythm: you start low and titrate upward every 4 weeks, without skipping steps. Going up fast doesn't slim more, it only sickens more (nausea, vomiting). Patience is literally the dose.
Minimum dose. The body gets used to the slow emptying. Here you install the habits that define everything: high protein and strength.
You step up one dose level. It starts to show. And here a key branch opens: the facial skin begins to sag with rapid loss — the "Ozempic face."
You keep rising to the effective dose. Muscle is defended with the recomposition stack. The metabolism is protected.
From the weight door, different paths open depending on what worries you besides losing:
Protein ~1.6 g/kg and strength training 2–4 times a week. Not optional: they're the #1 lever so the weight you lose is fat and not muscle. Without this, the best GLP-1 in the world leaves you worse than you started. (Full detail in Book V.)
The door of whoever wants their body to heal faster and better: the athlete, the injured, the gut that won't settle.
Here enters whoever has a tendon that won't close, a knee that's been dragging for months, an irritated gut that no diet change quite fixes. The star of this door is BPC-157 — the "body protection compound," a pleiotropic repairer that activates the formation of new vessels and the migration of fibroblasts right where the damage is. Its most robust lane is the gut; the second, localized injury.
This is one of the most important — and easiest to get wrong — decisions in the whole book:
TB-500 (and therefore Wolverine, Glow and Klow) mobilizes repair and new vessels — a theoretical signal of possibly feeding tumor tissue too. Contraindicated in active cancer or a history of it. And it's on the WADA list. BPC-157's evidence is robust in quantity but preclinical (animal); there are no published human efficacy trials. We say it clearly.
Episodic rhythm: used until resolved, not lifelong. A loading phase the first weeks, then maintenance, and it's withdrawn when the tissue responds. For a localized injury, near the area.
Avoid anti-inflammatories (ibuprofen, NSAIDs) unless a doctor indicates them. It sounds counterintuitive: controlled inflammation is part of repair, and NSAIDs shut it off — you brake exactly the signal you pay to activate. Add protein and vitamin C (collagen's raw material), reintroduce load progressively, and sleep: tissue repairs while sleeping.
The door of firmness, glow, and the time that shows in the mirror. Here you have to separate two things people confuse: firmness and tone.
Whoever crosses this door wants skin that looks firm, luminous, rested. The central tool is GHK-Cu, a copper tripeptide your own plasma carries and that drops with age. It stimulates fibroblasts and the synthesis of collagen and elastin — it literally tells the skin to rebuild. And it has something rare in this book: the best human evidence of all, topically, for wrinkles, firmness and density.
Two goals, two different compounds: GHK-Cu = firmness, collagen, structure. Glutathione = tone, glow, brightening. Glutathione does NOT give firmness, and its skin evidence is weak and mixed (its real strength is antioxidant/detox). Confusing them leads to buying what doesn't solve what you're after.
| Option | What it brings | When |
|---|---|---|
| GHK-Cu | Firmness, collagen, healing. High · topical | Pure skin goal. |
| Glow | GHK-Cu + repair (BPC/TB-500) | Skin + recovery together. |
| Klow | Glow + anti-inflammation (KPV) | Skin with background inflammation. |
| Glow Up | Glow + Glutathione (firmness + glow) | The complete aesthetic package — on different days. |
If you combine firmness and glow (Glow Up), glutathione and copper never go on the same day or in the same syringe — copper oxidizes glutathione and cancels it. They alternate. And if you use topical GHK-Cu, keep it apart from vitamin C: C by day, copper by night.
Cycled rhythm (8–12 weeks with rest, because of the copper). At night, rotating the site. The branches:
Sunscreen SPF 30+ every day. It's the #1 habit, no debate: the sun degrades the collagen and elastin GHK-Cu builds. Without protection, you undo by day what you build by night. Add: don't smoke (constricts capillaries, destroys collagen), sleep (skin renews at night), and dietary vitamin C as collagen's cofactor.
Not the energy of a coffee. The other one: made inside every cell, dimming little by little over the years.
Whoever enters this door isn't looking for a stimulant — they're looking to stop feeling like they're dragging. Real fatigue is almost never a lack of caffeine: it's the cell's power plant, the mitochondria, working worse with age. This door works in there, and it does so through three complementary routes that together form the Mito Stack.
| Piece | What it does | Metaphor |
|---|---|---|
| MOTS-c | Activates AMPK, raises fat oxidation. "Exercise mimetic." Preclinical | Tells the cell to "move." |
| SS-31 | Stabilizes the mitochondrial membrane (cardiolipin): more ATP, less oxidative stress. Best of the new ones | Repairs the plant. |
| NAD+ | Replenishes the coenzyme that drops with age. Weak by injection | The cofactor the machine burns. |
The beauty of the stack is that they don't overlap: MOTS-c signals, SS-31 structures, NAD+ supplies. Structure + signal + cofactor.
Injectable NAD+ raises the blood level, but raising it is not the same as a proven clinical benefit — the good human evidence is almost all oral. And there's a signal it may subtract from exercise's benefit on glucose. So: it's a base for energy/longevity, not a weight-loss piece, and it's kept apart from exercise. It also causes "flush" (heat, redness) — start low and slow.
MOTS-c in the morning or before training (catch the peak during effort), cycled. SS-31 at the same time, rotating site. NAD+ slow and in the morning. The branches:
Move. MOTS-c and exercise activate the same pathway (AMPK): without movement you leave half the benefit on the table. On the day you apply MOTS-c, do cardio. Add sleep (mitochondrial repair happens while sleeping) and, for NAD+, avoid alcohol — metabolizing it literally consumes the NAD+ you replenish.
Two wishes that seem opposite — focus more and worry less — solved by a pair that works in shifts.
Through this door enters whoever wants to think sharply, retain what they read, not lose the thread mid-afternoon; and also whoever wants to lower the noise, the background anxiety, the stress that won't let go. They seem like opposite goals, but they're solved by two sibling peptides that raise the same brain protein — BDNF, the neurons' "fertilizer" — and split the day between them.
| Compound | Role | When |
|---|---|---|
| Semax | Activation, focus, memory, attention | Morning (AM) |
| Selank | Calm without sedation, mood, less anxiety | Afternoon/evening (PM) |
| Calm Focus | Both, pre-mixed | The ready-made pair |
The order isn't optional: Semax activates, so it goes by day; Selank calms, so it goes in the afternoon. Reversed, they sabotage each other. And there's extra elegance: Selank "cleans up" in the afternoon the anxiety Semax's activation might leave. They're intranasal, not injected.
Semax and Selank have been used and approved in Russia for decades — there's a real floor of clinical use. But Western evidence is limited Medium-low: the mechanistic base (BDNF/NGF) is solid, but the effect on healthy cognition is partly extrapolation. It's not oversold.
Cycles of 1–3 weeks. The branches:
Exercise and sleep. Exercise is one of the biggest natural inducers of BDNF — the same pathway these peptides stimulate. And BDNF, memory and learning consolidation depend on sleep. Moderate afternoon caffeine: it clashes with the calm you want and ruins your rest.
The most ambitious and the most humble door at once: wanting to age slowly, with the honesty that here the science is still being written.
Whoever crosses this door has no symptom to cure — they have a horizon to protect. They want to go far with energy, defenses and a clear head. It's the most fascinating and most speculative territory of the book: the mechanisms are elegant, but the long-term human evidence is, almost always, limited. We say it straight and it's still worth it, because several of these compounds replenish messengers that time lowers.
The heart of this door is Epithalon, a tetrapeptide that mimics a pulse from the pineal gland. It's credited with effects on telomerase (in vitro) and the normalization of melatonin and the circadian rhythm. In animals it extended lifespan and reduced tumors; in humans there are Russian follow-ups of lower mortality in the elderly, but without independent replication Human limited.
It doesn't go in a daily stack. Its logic is an isolated pineal pulse: short courses of 10–20 days, 1–2 times a year, at night. It's the exception to almost everything else — you do its cycle, rest for months, and repeat. Lengthening it doesn't improve it; its (limited) evidence is about short pulses.
Around Epithalon, combinations are built depending on what you want to boost:
| Stack | Combines | Focus |
|---|---|---|
| Longevity Stack | Epithalon + Mito Stack (MOTS-c, SS-31, NAD+) | Anti-aging + cellular energy |
| Apex Longevity | Epithalon + MOTS-c + SS-31 + NAD+ + Glutathione | The complete package, with the master antioxidant |
Regular sleep in the dark, dietary antioxidants, and avoiding alcohol. Epithalon aims to normalize your clock — chaotic schedules and screens at night row against it. Glutathione is depleted by alcohol (it's consumed to detoxify). Here, more than in any door, the habits are the protocol.
The most direct door: one compound, one goal, and a key difference from what people believe.
This door has a single tool and needs no more: PT-141 (bremelanotide). And it brings a distinction to understand before using it: it doesn't work like Viagra. Viagra is vascular — it solves the mechanics of blood flow. PT-141 acts in the brain, on desire. It works the drive, not the plumbing. That's why it helps in cases where the problem isn't circulation but wanting.
It's one of the few compounds in the book FDA-approved High · FDA (for female hypoactive sexual desire), with two phase-3 trials. The effect is modest but real and reproducible. In men it's used off-label, with older evidence.
~1.75 mg subcutaneous about 45 minutes before — the effect on desire takes time to rise, using it "in the moment" arrives late. Maximum 1 every 24 hours and no more than 8 a month. Generally goes alone.
The #1 effect is nausea (~40%) — the main reason for quitting. And it raises blood pressure transiently: caution if you have hypertension, check it. Eat light before and avoid alcohol to reduce the nausea.
Here "maximizing" is mostly context: since it acts on desire, it's sensitive to your mental state. A relaxed setting, no rush or stress, with the 45-minute anticipation respected, is what separates a good experience from a failed one. Hydration and a light meal beforehand to manage the nausea.
You chose your door. Now the practical part: choose, reconstitute, apply and follow your protocol. Step by step, leaving nothing to chance.
Your kit arrived. Inside there's a vial of powder, water to mix it, and syringes. This is what nobody should improvise — and you don't have to: the app walks you through every step.
A peptide comes as lyophilized powder — dry, so it survives shipping. Before using it you have to return it to liquid (reconstitute it), measure the exact dose, and apply it under the skin. It sounds like a lot; in practice it's a few minutes and three clear moments. This chapter covers all four: choose, reconstitute, apply and follow your chosen protocol. Everything you see here is the same the app guides you through on your phone, with reminders and calculations done for you.
It all starts at the door (Book II): you choose the benefit, and with it your kit. Each kit already includes what the protocol needs — the peptide vial, the bacteriostatic water to mix it, and the syringes. You don't have to buy anything separately.
When you choose, you also choose a level — Essential, Complete or Maximum — depending on how much you want to cover and your budget. And above all, you choose a protocol type: not all are used the same. Recognizing yours is what makes the calendar make sense.
| Your protocol is of type… | Means | Examples |
|---|---|---|
| Titration | The dose rises in steps: you start low, go up every few weeks to your effective dose. | Retatrutide, Tirzepatide |
| Cycled ON/OFF | Periods of use with rests, repeated. | Tesamorelin, MOTS-c, SS-31, GHK-Cu, Glow, Klow, Semax, Selank |
| Load → maintenance | Intense start, then a gentler hold. | NAD+, TB-500 (in Wolverine/Glow/Klow) |
| Pulses | Short course, long rest. 1–2 times a year. | Epithalon |
| Episodic | Acute phase until resolved, then it ends. | BPC-157, Wolverine |
| On demand | No phases: used the moment it's needed. | PT-141 |
| Sequential | A plan that starts with one thing and ends with another (phased routes). | Stacks / recomposition |
The calendar can't assume "same dose always." A GLP-1 rises in steps; the GH axis rests; Epithalon is a once-a-year pulse. The app generates the correct phase per product and tells you when you change phase — you just follow the signal.
Reconstituting is returning the powder to liquid by mixing it with the kit's bacteriostatic water. It's the most delicate step and the easiest to do well if you respect the order. The app guides it vial by vial; here's the complete sequence.
Soap and water, 20 seconds. It's the step that prevents most contamination.
Don't twist them: hold the vial firmly and pry. They come off once and don't go back on.
An alcohol wipe for the peptide stopper and a separate one for the water. Let them dry.
Pierce the water stopper, flip the vial upside down and pull the amount the app tells you. Upside down, no bubbles enter.
With the peptide vial upright, let the water slide down the glass wall — never a jet straight onto the powder.
A soft circular swirl until it's clear. Don't shake: shaking fragments the peptide.
Between 2 and 8 °C, away from light. Never freeze it. Shelf life reconstituted: ~60 days — the app keeps the count.
The dose is tiny and goes under the skin (subcutaneous), with a very fine needle like insulin's. Your dose is in milligrams, but it's measured in units on the syringe — and that calculation the app does for you. You just follow the steps.
Applying cold liquid stings more; at room temperature you barely feel it.
An alcohol wipe over the vial stopper. Let it dry a few seconds.
With the vial upright, pull the plunger to your dose's units and inject that air in. It equalizes pressure and the liquid comes out on its own.
Without removing the syringe, flip the vial upside down and pull to your units. Keep the tip always inside the liquid.
Needle up, tap the syringe so they rise, and push just enough to expel them.
With another alcohol wipe (one for the vial, another for the skin), clean where you'll inject.
Pinch the skin gently, insert the needle at 45° and inject slowly and firmly. Release the pinch when done.
In a safe container. Never reuse or share the needle.
Abdomen (a couple of fingers from the navel), thigh, or back of the arm. Keep changing the spot each application to protect the skin and absorb well. The app suggests where.
Injecting once is easy; what gives results is completing the phases. This is where the protocol type you chose becomes a concrete calendar, and where the app stops being a step guide and becomes your continuity copilot:
The protocol isn't the first injection. It's the last phase, complete.
All of this is Research Use Only (RUO) material and doesn't replace the judgment of a health professional. If you have a medical condition, take medication, or have doubts, check first. And remember the hard rules of Ch. 3: what doesn't mix, doesn't mix — the phased calendar is designed precisely so they never coincide.
The honest profile of each compound. Mechanism, real evidence, dose, safety. No dressing up.
No narrative here: just data. To consult once you know which door you walked through.
Evidence is marked honestly: High/FDA = human, approved · Medium = partial trials or regional clinical use · Preclinical = animal / in vitro / community. WADA = banned in competitive sport. Reference prices in USD.
A blend is a pre-mixed vial (applied as one); a stack is several vials, each active in its phase. Here's the recommended protocol for each.
The other half of the work. The half that doesn't come in a vial.
The peptide opens the door. These habits decide how far you get in. Without them, you leave half the benefit uncollected.
The prologue's thesis returns, now with numbers and reasons: the peptide is a tool. A hammer doesn't build a house alone. Every compound has a handful of habits that boost it — and one or two that, if you ignore them, sabotage the whole protocol. We mark them by weight: Critical moves the result a lot; Recommended adds. And honestly: [science] = physiological backing of the compound; [common sense] = coherent logic, not direct evidence.
If you only take five things from this book, make them these — they move the needle the most and the most people skip them:
Four things show up in almost every door — sleep 7–9 h, hydrate, enough protein, and moderate alcohol — but the why changes. Water on a GLP-1 is against nausea; on glutathione it's for detox. It's not a generic: each door uses it for a different reason. That's the difference between "taking peptides" and using them well.
The minimum vocabulary to read this book (and any peptide conversation) without getting lost.
| Term | What it means |
|---|---|
| Peptide | Short chain of amino acids (under ~50). A brief "signal" for the body. |
| GLP-1 | Class of compounds that mimic appetite hormones (incretins). Reta, Tirze. |
| GH axis | The growth-hormone system. Tesamorelin stimulates it. |
| IGF-1 | Growth factor that rises with the GH axis. Watched because in excess it's mitogenic. |
| AMPK | The cell's energy switch. Exercise and MOTS-c activate it. |
| BDNF | The neurons' "fertilizer." Semax and Selank raise it. |
| Blend | One vial with several pre-mixed actives. |
| Stack | Several separate vials used as one plan, on different schedules/days. |
| Titrate | Raise the dose in steps, slowly, so the body adapts. |
| Cycle | Alternate periods of use and rest. |
| SC (subcutaneous) | Under the skin, into the fat. The typical route. |
| RUO | Research Use Only — material for research, not approved as consumer medicine. |
| WADA | World Anti-Doping Agency. Several compounds are banned in competition. |
This book was built on SuperBio Labs' component dossier, which in turn cites research from PubMed/NCBI, the FDA, phase trials, dermatology, sports medicine and gerontology (2024–2026). The best-backed molecules — Tirzepatide (SURMOUNT-1, NEJM), Retatrutide (Jastreboff, NEJM 2023), PT-141 (FDA Vyleesi), Tesamorelin (FDA Egrifta), topical GHK-Cu (Pickart & Margolina), SS-31 (FDA approval 2025) — are marked with high evidence. Compounds backed only by preclinical or community practice are marked as such, without exception.
All the content of this Bible is Research Use Only (RUO) material. Trial figures correspond to the molecules studied, not to result promises from a SuperBio Labs product. None of this is medical advice. Before starting any protocol, consult a health professional — especially if you have a medical condition, take medication, are pregnant, or compete in regulated sport.